The global health and wellness market is entering a defining decade, fuelled by innovation, demographic change and shifting consumer expectations.
According to Corlytics, health products, spanning pharmaceuticals, medical devices and wellness solutions, sit at the heart of the wider Health and Life Science sector, which is projected to grow from more than $8tn in 2025 to over $15tn by 2035.
This expansion reflects a convergence of forces, including rising disease prevalence, rapid technological progress and increasing public and private investment in healthcare systems worldwide.
Chronic and lifestyle-related conditions such as diabetes, cardiovascular disease, cancer and mental health disorders are placing sustained pressure on healthcare providers and governments alike. In response, innovation across personalised medicine, digital health and telemedicine is reshaping how care is delivered and managed. Consumers are also becoming more proactive, driving demand for prevention-led health products, lifestyle management tools and technology-enabled wellness solutions. Together, these trends are broadening the definition of health products to include pharmaceuticals and biologics, medical devices, complementary and herbal medicines, dietary supplements, functional foods, personal care products, cosmetics, wellness devices and digital health platforms.
As the market expands, regulation has become a critical pillar in protecting public health while enabling innovation. Health product regulation is designed to ensure safety, quality and efficacy throughout the product lifecycle, from development and approval to post-market surveillance.
However, the rapid pace of scientific and technological advancement has created a complex and evolving regulatory environment. Regulatory Affairs Professionals now play a central role as intermediaries between companies and authorities, overseeing submissions, shaping regulatory strategy and navigating approval processes to support timely market entry.
This role is becoming more demanding as regulatory complexity increases. Constant regulatory change requires ongoing monitoring and adaptation, while the globalisation of health product companies has multiplied jurisdictional requirements and standards. Emerging technologies such as artificial intelligence and big data analytics are influencing both product development and regulatory workflows, raising new questions around governance and compliance.
At the same time, maintaining data integrity and transparency remains essential, particularly as regulatory scrutiny intensifies and expectations around evidence and reporting continue to rise. Resource pressures are also mounting, with regulatory teams often expected to manage simultaneous submissions across multiple markets with limited capacity.
Looking ahead, several trends are set to redefine regulatory practice. Digital transformation is accelerating, with electronic submissions, cloud-based platforms and AI-driven regulatory intelligence tools becoming increasingly mainstream. Regulators are placing greater emphasis on real-world evidence to support decision-making, while risk-based approaches are being embedded into new frameworks such as the EU MDR and FDA QSMR. Many authorities are also positioning themselves as enablers of innovation, encouraging earlier engagement with industry to help translate research into approved, commercially viable products.
In this environment, regulatory strategy has become a source of competitive advantage rather than a purely compliance-driven function. An effective strategy aligns product development with regulatory expectations from the outset, helping organisations manage risk, optimise timelines and unlock global market access. Technology is playing a growing role in this shift. Solutions such as Corlytics support regulatory teams by delivering timely regulatory intelligence, enabling smarter planning, more efficient submissions and improved engagement with health authorities across jurisdictions.
As regulatory timelines tighten and global complexity increases, the ability to anticipate change and respond strategically will define success. Future discussions will explore how health product regulation is evolving as the industry approaches 2026, and how technology is transforming regulatory practice worldwide.
Read the daily RegTech news
Copyright © 2025 RegTech Analyst
Copyright © 2018 RegTech Analyst
